Barclays Starts Protagonist Therapeutics (PTGX) at Overweight

September 6, 2016 6:57 AM EDT
Get Alerts PTGX Hot Sheet
Price: $22.10 +0.50%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade PTGX Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Barclays initiated coverage on Protagonist Therapeutics (NASDAQ: PTGX) with an Overweight rating and a price target of $18.00.

For an analyst ratings summary and ratings history on Protagonist Therapeutics click here. For more ratings news on Protagonist Therapeutics click here.

Shares of Protagonist Therapeutics closed at $12.08 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities


Add Your Comment